Viewing Study NCT05659251


Ignite Creation Date: 2025-12-24 @ 11:48 PM
Ignite Modification Date: 2025-12-25 @ 9:42 PM
Study NCT ID: NCT05659251
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-02
First Post: 2022-12-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module